Gold prices cool after rallying on Powell rate cut talk
Control Empresarial de Capitales S.A. de C.V., a significant shareholder in ProKidney Corp. (NASDAQ:PROK), has increased its stake in the company through recent purchases. On April 10 and April 11, the firm acquired a total of 1,034,118 Class A Ordinary Shares. These transactions were executed at a weighted average price of $0.6081 per share, with prices ranging from $0.575 to $0.61 on April 10 and from $0.6057 to $0.61 on April 11. The timing is notable as PROK shares have surged 23.5% in the past week, though they remain down 58% over the past six months. According to InvestingPro analysis, the stock is currently trading above its Fair Value.
The total value of the shares purchased amounts to approximately $628,847. Following these acquisitions, Control Empresarial de Capitales now holds 72,594,225 shares of ProKidney Corp., reinforcing its position as a key stakeholder in the company with a significant interest in the $214 million market cap firm. InvestingPro data shows the company maintains strong liquidity with a current ratio of 10.93, though it faces challenges with rapid cash burn.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.